Nanomedicine could reduce the frequency of breast and ovarian cancer treatments, research finds

A Northeastern University researcher is using nanomedicine to develop a time-released immunomodulatory treatment that would lengthen time between hospital visits for patients fighting advanced breast cancer.

Most cancer drugs require continual daily or weekly delivery, leading to frequent hospital visits, says Needa Brown, an assistant teaching professor of physics at Northeastern.

“It’s not the best quality of life for the patient,” says Brown, who is also Northeastern’s program director of the Nanomedicine Graduate Certificate and Master of Science program, which launched in the fall.

Read more from Northeastern Global News 

Photo by Matthew Modoono/Northeastern University